Cargando…
Immunohistochemical Screening of HER2 in Canine Carcinomas: A Preliminary Study
SIMPLE SUMMARY: The human epidermal growth factor receptor-2 (HER2) has been studied in many human carcinomas. This receptor can be amplified and overexpressed in tumoral cells and serve as a prognostic, therapeutic, and predictive biomarkers. In human medicine there are many target drugs direct aga...
Autores principales: | Brunetti, Barbara, Bacci, Barbara, Sarli, Giuseppe, Pancioni, Elisa, Muscatello, Luisa Vera |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065471/ https://www.ncbi.nlm.nih.gov/pubmed/33916691 http://dx.doi.org/10.3390/ani11041006 |
Ejemplares similares
-
High Intrinsic Expression of P-glycoprotein and Breast Cancer Resistance Protein in Canine Mammary Carcinomas Regardless of Immunophenotype and Outcome
por: Levi, Michela, et al.
Publicado: (2021) -
HER2 Overexpression and Cytogenetical Patterns in Canine Mammary Carcinomas
por: Muscatello, L. V., et al.
Publicado: (2022) -
Molecular portrait-based correlation between primary canine mammary tumor and its lymph node metastasis: possible prognostic-predictive models and/or stronghold for specific treatments?
por: Beha, Germana, et al.
Publicado: (2012) -
Pathological Findings of Canine Idiopathic Pericarditis and Pericardial Mesotheliomas: Correlation with Clinical and Survival Data
por: Levi, Michela, et al.
Publicado: (2021) -
Validation of p53 Immunohistochemistry (PAb240 Clone) in Canine Tumors with Next-Generation Sequencing (NGS) Analysis
por: Brunetti, Barbara, et al.
Publicado: (2023)